Filed: 11/13/2025ACC: 0001395064-25-000157
📋 What this filing means
TAKEDA PHARMACEUTICAL CO LTD filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $16.37M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$16.37M
Total AUM (reported)
11.70M
Total Shares
Allocation by class
COM$16.37M100.0%
Portfolio Concentration
Top 3$13.64M83.4%
4–10$2.72M16.6%
Top 3 weight
83.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.70M
Sole
Full voting authority
11.70M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other8
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
Ovid Therapeutics, Inc.
DFNDShares7.53M
TypeSH
Market value$9.79M
59.82%
Sole
7.53M
Shared
0.00
None
0.00
Equillium, Inc.
DFNDShares1.82M
TypeSH
Market value$2.61M
15.94%
Sole
1.82M
Shared
0.00
None
0.00
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)
DFNDShares1.48M
TypeSH
Market value$1.24M
7.59%
Sole
1.48M
Shared
0.00
None
0.00
Shattuck Labs, Inc.
DFNDShares515.62K
TypeSH
Market value$1.23M
7.53%
Sole
515.62K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
DFNDShares54.89K
TypeSH
Market value$891.4K
5.45%
Sole
54.89K
Shared
0.00
None
0.00
American Well Corporation
DFNDShares77.73K
TypeSH
Market value$478.1K
2.92%
Sole
77.73K
Shared
0.00
None
0.00
Rani Therapeutics Holdings, Inc.
DFNDShares203.19K
TypeSH
Market value$101.6K
0.62%
Sole
203.19K
Shared
0.00
None
0.00
Standard Biotools, Inc.
DFNDShares16.52K
TypeSH
Market value$21.5K
0.13%
Sole
16.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Ovid Therapeutics, Inc.DFND | COM | 7.53M | SH | $9.79M 59.82% | 7.53M | 0.00 | 0.00 |
Equillium, Inc.DFND | COM | 1.82M | SH | $2.61M 15.94% | 1.82M | 0.00 | 0.00 |
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)DFND | COM | 1.48M | SH | $1.24M 7.59% | 1.48M | 0.00 | 0.00 |
Shattuck Labs, Inc.DFND | COM | 515.62K | SH | $1.23M 7.53% | 515.62K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.DFND | COM | 54.89K | SH | $891.4K 5.45% | 54.89K | 0.00 | 0.00 |
American Well CorporationDFND | COM | 77.73K | SH | $478.1K 2.92% | 77.73K | 0.00 | 0.00 |
Rani Therapeutics Holdings, Inc.DFND | COM | 203.19K | SH | $101.6K 0.62% | 203.19K | 0.00 | 0.00 |
Standard Biotools, Inc.DFND | COM | 16.52K | SH | $21.5K 0.13% | 16.52K | 0.00 | 0.00 |